Differentiating between malignant and benign strictures remains challenging
A delayed diagnosis of malignancy may result in a more invasive surgical procedure3 or patients may no longer be surgical candidates.4
Accurate diagnosis is as challenging as it is important1,2,5,6
Optimizing hospital resources – an urgent requirement
Strain on health systems has been exacerbated by the COVID-19 pandemic, resulting in patient backlogs and driving the need for improved operational efficiency.
“It has been sobering to witness first-hand the immense pressures we are all feeling on our time and our resources, especially during the COVID-19 pandemic, but also inspiring to see so many innovative solutions, and to share those learnings in the hope of achieving better outcomes for patients and providers alike.”7
This can be achieved by avoiding repeat procedures, reducing the length of those that are carried out, and delivering cost savings while simultaneously maintaining – or improving – the standard of care.
Driving innovation in HPB diagnosis
Direct visualization
The SpyGlass™ DS System directly visualizes the pancreatic bile ducts and improve the success of diagnostic procedures
Biopsy forceps
Secure a diagnosis for your patient with the sample you need with the
SpyBiteTM Max
Fine-needle biopsy
Obtain more tissue with the Acquire™ Endoscopic Ultrasound Fine-Need Biopsy Device